Ambry Genetics Overview
- Year Founded
-
1999

- Status
-
Acquired/Merged
- Employees
-
748

- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
Ambry Genetics General Information
Description
Operator of a genetics diagnostics company intended to provide a comprehensive suite of genetic testing applications for inherited and non-inherited diseases. The company includes gene testing, classification, sequencing and conducting scientific research studies by collaborating with clinicians, patients and researchers, enabling medical professionals to share patient records with the global medical research community to fulfil the promise of the human genome to cure or manage human disease.
Contact Information
Website
www.ambrygen.com(Operating Subsidiary)
Corporate Office
- 1 Enterprise
- Aliso Viejo, CA 92656
- United States
Corporate Office
- 1 Enterprise
- Aliso Viejo, CA 92656
- United States
Ambry Genetics Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Ambry Genetics Comparisons
Industry
Financing
Details
Ambry Genetics Competitors (27)
One of Ambry Genetics’s 27 competitors is Admera Health, a Venture Capital-Backed company based in South Plainfield, NJ.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Admera Health | Venture Capital-Backed | South Plainfield, NJ | ||||
BGI Genomics | Formerly VC-backed | Shenzhen, China | ||||
Igenomix | Formerly PE-Backed | Miami, FL | ||||
MedGenome | Venture Capital-Backed | Wilmington, DE | ||||
Genuity Science | Formerly VC-backed | Dublin, Ireland |
Ambry Genetics Patents
Ambry Genetics Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220307077-A1 | Conservative concurrent evaluation of dna modifications | Inactive | 24-Mar-2021 | ||
US-20200294618-A1 | Method to perform medical procedures on breast cancer patients guided by an snp derived polygenic risk score | Inactive | 12-Mar-2019 | ||
US-20190287681-A1 | Artificial intelligence and machine learning platform for identifying genetic and genomic tests | Inactive | 19-Mar-2018 | ||
JP-2021519479-A | Artificial intelligence and machine learning platforms for identifying genetic and genomic tests | Pending | 19-Mar-2018 | ||
US-20140088942-A1 | Molecular genetic diagnostic system | Inactive | 27-Sep-2012 | G16B50/10 |
Ambry Genetics Signals
Ambry Genetics Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Ambry Genetics Acquisitions (1)
Ambry Genetics’s most recent deal was a Merger/Acquisition with Progeny Software. The deal was made on 01-Apr-2015.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Progeny Software | 01-Apr-2015 | Merger/Acquisition | Database Software |
Ambry Genetics Affiliates
Subsidiaries (1)
Name | Industry | Location | Year Founded |
---|---|---|---|
Progeny Software | Aliso Viejo, CA | 1996 |
Ambry Genetics FAQs
-
When was Ambry Genetics founded?
Ambry Genetics was founded in 1999.
-
Where is Ambry Genetics headquartered?
Ambry Genetics is headquartered in Aliso Viejo, CA.
-
What is the size of Ambry Genetics?
Ambry Genetics has 748 total employees.
-
What industry is Ambry Genetics in?
Ambry Genetics’s primary industry is Biotechnology.
-
Is Ambry Genetics a private or public company?
Ambry Genetics is a Private company.
-
What is the current valuation of Ambry Genetics?
The current valuation of Ambry Genetics is
. -
What is Ambry Genetics’s current revenue?
The current revenue for Ambry Genetics is
. -
Who are Ambry Genetics’s investors?
Innovation Network Corporation of Japan, Konica Minolta, and REALM IDx have invested in Ambry Genetics.
-
Who are Ambry Genetics’s competitors?
Admera Health, BGI Genomics, Igenomix, MedGenome, and Genuity Science are some of the 27 competitors of Ambry Genetics.
-
When was Ambry Genetics acquired?
Ambry Genetics was acquired on 02-Feb-2025.
-
Who acquired Ambry Genetics?
Ambry Genetics was acquired by Tempus AI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »